Latest Australian Market News

Tyro Payments welcomes the Reserve Bank of Australia's reforms to merchant card payment costs, highlighting opportunities from increased transparency and competition. The changes, effective from October 2026, align with Tyro’s transparent pricing model and do not affect its near-term guidance.

ClearVue Technologies has achieved a key international certification for its innovative solar panels and is deepening its strategic alliance with Helios Power, setting the stage for expanded commercial deployment in the building-integrated photovoltaics market.

Shriro Holdings has introduced a new dividend policy aiming to distribute 20-30% of net profit after tax annually, balancing shareholder returns with capital needs. The Board retains discretion over payments, factoring in franking credits and strategic priorities.

Harmoney Corp Limited has reported a strong first half of 2026, surpassing previous full-year profits and upgrading its FY26 cash NPAT guidance to $13 million, driven by loan book growth and automation advances.

Synertec Corporation Limited has reported a robust first half of FY26, with a 20% increase in group revenue and a significant $135 million engineering tender pipeline, underscoring its growing footprint in energy technology and engineering services.

WhiteHawk Limited is realigning its leadership with an Australian-based Chair and CEO to capitalise on growing cybersecurity demands in the Asia Pacific region, while maintaining a strong foothold in the US market.

Vitura Health has inked a binding distribution agreement with MedReleaf Australia, unlocking access to a broad medicinal cannabis portfolio across its extensive pharmacy network. This deal could add up to AUD 15 million annually, positioning Vitura as a dominant player in the evolving Australian market.

Variscan Mines Limited has voluntarily suspended trading on the ASX pending a Supreme Court decision related to a regulatory compliance issue with a past share issue. The suspension highlights ongoing legal scrutiny and investor uncertainty.

Rhythm Biosciences has achieved a significant regulatory milestone with NATA accreditation for its ColoSTAT® blood-based colorectal cancer test, enabling its commercial rollout in Australia and strengthening reimbursement prospects.

RLF AgTech has built a promising $3 million sales pipeline in Australia from scratch while securing $7.2 million in pre-paid orders in China, signalling robust growth ahead of the 2026 season.

S&P Dow Jones Indices has announced its March 2026 quarterly rebalance, reshuffling key constituents across major S&P/ASX indices effective March 23. The update signals shifts in market representation with notable additions and removals.

Little Green Pharma Ltd (ASX: LGP) has proposed a full acquisition of Cannatrek Ltd via a scheme of arrangement, creating a vertically integrated medicinal cannabis group with pro forma FY26 revenues exceeding AUD 100 million. The scheme, supported by an independent expert, offers liquidity and strategic growth opportunities amid regulatory and market risks.